Lipohypertrophy

12 registered clinical trials studyying Lipohypertrophy.

Status	Trial	Sponsor	Phase
Completed	De-tensioning Patch, in Subjects With Type 1 Diabetes and Lipohypertrophy NCT06025513	Neodyne Biosciences, Inc.	N/A
Active Not Recruiting	The Use of Ultrasound Detection of Lipohypertrophy to Improve Glycemic Control NCT05377268	University of British Columbia	N/A
Completed	Impact of Two Medtronic Infusion Sets on Lipohypertrophy in Type 1 Diabetes (T1DM) Patients Thought to Have LH NCT06074965	Azienda Ospedaliera San Camillo Forlanini	N/A
Completed	The Visceral Adiposity Measurement and Observation Study NCT05383456	Theratechnologies	—
Withdrawn	Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique NCT03229850	Graydon Meneilly	N/A
Completed	The Role of Proper Insulin Injection Technique in the Treatment of Diabetes Mellitus NCT04120974	Becton, Dickinson and Company	N/A
Active Not Recruiting	Effects of Semaglutide in HIV-Associated Lipohypertrophy NCT04019197	Case Western Reserve University	Phase 2
Completed	Lipohypertrophy Monitoring Study NCT04659330	University Hospital, Antwerp	N/A
Completed	Ultrasound Classification and Grading of Lipohypertrophy and Its Impact on Glucose Variability in Type 1 Diabe NCT03669770	King's College London	—
Active Not Recruiting	Glucose Variability in Subclinical Hypertrophy NCT02748434	University of British Columbia	N/A
Terminated	Ultrasound Detection and Characterization of Subclinical Hypertrophy in Diabetes NCT02348099	University of British Columbia	—
Terminated	Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy NCT01420523	ANRS, Emerging Infectious Diseases	Phase 2